CLICK HERE TO SUBMIT AN ABSTRACT

Obesity and Hypertension in Canada: From Science to Solutions Call for Abstracts, Workshops & Symposia

Obesity Canada and Hypertension Canada are pleased to announce a call for abstracts for our co-hosted conference, to take place in Banff, Alberta Canada April 3-6, 2024. The Call for Abstracts opens November 20, 2023, and closes January 12, 2024, at 11:59 pm EDT. Decisions will arrive by email from cos@scolars.com. Accepted abstracts will be presented in person in Banff, AB during the conference. You must register and attend in person should your application be accepted. There is no cost to submit an abstract.

All abstracts must follow Obesity Canada’s Person first language policy, which can be reviewed here. 

All presenters must use non-stigmatizing images. Use images from Obesity Canada or their partner’s image banks by clicking here. 

Hypertension Canada supports the policies of Obesity Canada.

All submissions will be evaluated as to their content, quality and appropriateness to overall conference core themes.

Decisions will arrive by the end of January 2024 from cos@scolars.com.

The Executive Scientific Planning Committee invites submissions of abstracts for poster, oral, workshop and symposia presentations relating to the following four core themes around which the conference will be developed:

Core Themes

  1. Environmental and Socio-Cultural Determinants
  2. Behavioural and Biological Determinants
  3. Prevention, Treatment, and Rehabilitation
  4. Health Economics and Policy

Sub-Themes

  • Basic science – cellular, molecular, physiological, or neuronal related aspects of obesity or hypertension
  • Epidemiology – epidemiological techniques/methods to address obesity or hypertension related questions in population studies
  • Prevention of obesity or hypertension and health promotion interventions – research targeting different populations, settings, and intervention levels (e.g. community-based, school, workplace, health systems, and policy)
  • Weight bias and weight-based discrimination – including prevalence studies as well as interventions to reduce weight bias and weight-based discrimination; both qualitative and quantitative studies
  • Pregnancy and maternal health – studies across clinical, health services, and population health themes
  • Childhood and adolescent obesity or hypertension – research conducted with children and or adolescents and reports on the correlates, causes, and consequences of pediatric obesity or hypertension as well as interventions for treatment and prevention.
  • Obesity or Hypertension in adults and older adults – prevalence studies and interventions to address obesity in these populations
  • Health services and policy research – research addressing issues related to obesity or hypertension management services which identify the most effective ways to organize, manage, finance, and deliver high quality care, reduce medical errors, or improve patient safety
  • Bariatric surgery – issues that are relevant to metabolic or weight loss surgery
  • Clinical management – clinical management across the life span (infants through to older adults) including interventions for prevention and treatment of obesity and weight-related comorbidities including hypertension 
  • Rehabilitation –  investigations that explore opportunities for engagement in meaningful and health-building occupations for people with obesity and or hypertension
  • Diversity – studies that are relevant to diverse or underrepresented populations
  • Virtual technology – research that incorporates social media, the internet and/or mobile devices in prevention and treatment
  • Comorbidities and other chronic diseases – research relevant to obesity and hypertension  e.g. cancer, cardio-metabolic, nonalcoholic steatohepatitis 
  • Indigenous health: prevention and management research with Indigenous peoples (i.e., First Nations, Inuit, and Métis and/or Urban Indigenous communities) that is strengths-based, solutions-focused, innovative, Indigenous community-led, recognizing that obesity and hypertension  in Indigenous communities co-occur and interacts with complex social, cultural, environmental, and patient behavioral factors
  • Planetary health: research that explores opportunities to address the impact of planetary health decisions on chronic disease management. 

The goals of this Conference are:

  • Deliver an engaging in-person event that brings together healthcare professionals and providers who are excited to learn about the latest research trends and treatment methods surrounding hypertension and obesity.
  • Offer a platform for those in the industry, research field, and the healthcare community to explore the ways in which diagnosis and treatment of hypertension has shifted since the beginning of the pandemic.
  • Educate healthcare professionals and providers on best practices for the treatment of obesity and hypertension.
  • Provide opportunities for students and trainees to share their research around hypertension, expand their networks, and grow their careers. 
  • Provide an opportunity for healthcare professionals to obtain CME credits by taking in-person training from leading experts in the field. 

To provide education and networking opportunities for creating inter-sectoral and patient-centered research and knowledge translation collaborations. The conference will bring together approximately 700 participants from a wide range of educational institutions, governmental and non-governmental agencies, and the private sector.

Submission Website: Click HERE to submit an abstract or cut and paste the following link into your browser: https://www.s2sabstracts.ca/

You will need to set up a free personal account in which you can create, edit, and submit abstracts. You may submit more than one abstract using the same account. Please fill in all of the required fields. Abstracts sent by email, mail, or fax will not be accepted. 

If you have questions about completing the application form, contact the Abstract Manager cos@scolars.com.

Abstract submissions must use inclusive language and non-stigmatizing images.  People-first language is the standard for respectfully addressing people with chronic disease, rather than labeling them by their illness (i.e., the obese patient or the hypertension patient). Because of the importance of reducing bias associated with obesity, authors should not use “obese” or “hypertensive” as an adjective or noun to describe an individual person or group of people, but instead use terms such as “people with obesity/hypertension”,  this also includes language and image that could be interpreted as stereotyping, biased, or prejudiced.

Submission Confirmation

Upon successful submission using the online submission website, the presenting author (and additional email address if provided) will instantly receive an acknowledgment of receipt. Please contact cos@scholars.com if you do not receive an email confirmation after submitting your abstract or proposal, but be sure to first check Spam/Junk folders. Confirmation of receipt does not confirm the acceptance of the abstract to the conference. Authors may check the status of their abstract or proposal at any time by logging into their account.

Notice of decision (e.g. Acceptance of abstract for presentation at the conference) will be communicated by the end of January 2024. An email will be sent to all authors when the results are available.

Orals & Posters

  • Presentations will be in person in Banff and you MUST be willing to travel

Proposals for Workshops & Symposia

You may submit proposals for 90-minute workshops on a topic of interest to the community. Short biographies (up to 250 words) and headshot images (labeled with last name, first name)  for the primary presenter and all co-presenters participating are submitted;

Due to the VERY limited space, workshops that incorporate pan-Canadian or multi-team proposals will be given priority. 

All abstracts must follow the following format: 

All authors’ names and affiliations/institutions will be requested during the submission process and should not be entered in the abstract text section. All abstracts must be submitted in English. 

Example abstract:

Metabolic Syndrome May be Associated with Some Cancers

Introduction: Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Methods: Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Results: Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Conclusion: Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Funding: No Funding/Research relating to this abstract was funded by ……

  • Authors with multiple abstracts should list their names the same way on all submissions.
  • All abstracts and proposals must be submitted in blinded format. Identifiers such as city, province, or institution name should not be included within the title or body of abstract..
  • The use of standard abbreviations is required. Examples include kg, g, mg, ml, L (liter), meq, m (meter), mmol/L (millimoles per liter), and % (percent). Abbreviated terms should be expanded at first mention with the abbreviation in parentheses. Then the abbreviation used throughout the rest of the submission. Use numerals to indicate numbers, except when beginning sentences.
  • Non-proprietary (generic) names should be used the first time a drug is mentioned and typed in lowercase letters; trade names are always capitalized, for example, aspirin (Bufferin).
  • Within the online form, indicate the appropriate theme and sub-theme under which you wish to have the abstract reviewed. The Committee reserves the right to move an abstract that has been inappropriately categorized without notifying the author(s).
  • All submitting and presenting authors must complete a declaration of conflict of interest as part of the submission process.
  • The information requested for the presenting author must be provided. The presenting author will receive notification of abstract or proposal status. Should the presenting author prefer, another email address may be submitted for correspondence and notification of status.

Originality of work, adequacy of data and clarity of exposition are the determinants in the selection process. Make abstracts and proposals as informative as possible.

  • Abstracts must contain plain text only (no symbols, mathematical formulas, formatted text, etc.)
  • Tables, figures and images are not allowed (please do not attempt to create tables with tabs or spaces)
  • Abstracts must not contain footnotes or references.
  • Ensure that Institutional Affiliations are entered completely and correctly for ALL authors (list in the order of authorship, separated by a semi-colon).
  • Abstracts and proposals that do not meet the above criteria will not be considered.

*Please note that all criteria will be checked and abstracts that do not adhere to the criteria will not be considered.

  • Abstract open: November 20, 2023
  • Registration open: November 20, 2023 
  • Abstract deadline: January 12, 2024
  • Notification of decision: On or before January 31, 2024
  • Deadline for accepted abstract video: February 29, 2024
  • Early Bird Registration deadline: February 16, 2024

*all abstract submitters should be registered to the conference prior to the early bird registration deadline.

Questions?

Questions about submissions should be directed to cos@scolars.com but eligibility questions or general questions may be submitted to pearce@obesitycanada.ca.